Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:31 AM UTC
| NCT Number | NCT03786796 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | March 30, 2026 (Mar 30, 2026) |
As of July 17, 2026: Clinical trial NCT03786796 is currently recruiting participants. This phase2 study for renal cell carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03786796 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03786796 was last updated Mar 30, 2026 (March 30, 2026). HelloStudys verifies this status automatically.